Zafer Haydar
El Paso, TXNPI 1922040658
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 196 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 22.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,520 and has fallen 76.6% since, to $356 in 2021.
Across 196 payments — averaging $15.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$709
- Novo Nordisk$393
- AbbVie$381
- Johnson & Johnson$202
- Pfizer$172
- Sanofi-aventis U.S. LLC$144
- plus $1K from 18 others
What the payments were for
- Food & beverage$3,125100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 38 | $709 |
| Novo Nordisk | 25 | $393 |
| AbbVie(2 entities) | 39 | $381 |
| Johnson & Johnson(2 entities) | 11 | $202 |
| Pfizer | 10 | $172 |
| Sanofi-aventis U.S. LLC | 5 | $144 |
| GSK | 9 | $135 |
| Lilly USA, LLC | 10 | $133 |
| Amarin Pharma, Inc. | 1 | $125 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $118 |
| Astellas Pharma US Inc | 5 | $107 |
| Novartis | 7 | $106 |
| Kowa Pharmaceuticals America, Inc. | 5 | $71 |
| Boehringer Ingelheim | 3 | $60 |
| Abbott | 3 | $46 |
| Merck | 3 | $36 |
| Amgen | 2 | $35 |
| Arbor Pharmaceuticals, Inc. | 3 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33 |
| Radius Health, Inc. | 2 | $27 |
| Mylan Specialty L.p. | 2 | $25 |
| Genentech USA, Inc. | 1 | $14 |
| Eisai Inc. | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Vascepa$125
- RYBELSUS$125
- BREZTRI AEROSPHERE$120
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.